Nycomed Overview
- Year Founded
-
1873
- Status
-
Acquired/Merged
- Employees
-
12,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
10
- Investments
-
9
Nycomed General Information
Description
Manufacturer of pharmaceutical and OTC drugs catering to Europe and emerging markets. The company offers a diversified product portfolio for the treatment of gastroenterology, cardiovascular, inflammatory and immune disorders, respiratory as well as oncology diseases, thereby contributing to improving patient health.
Contact Information
Website
www.nycomed.comCorporate Office
- Thurgauerstrasse 130
- Glattpark, Opfikon
- 8152 Zurich
- Switzerland
Corporate Office
- Thurgauerstrasse 130
- Glattpark, Opfikon
- 8152 Zurich
- Switzerland
Nycomed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nycomed Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nycomed Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nycomed Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nycomed Investments & Acquisitions (9)
Nycomed’s most recent deal was a Buyout/LBO with Laboratorios Farmacol. The deal was made on 04-Feb-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Laboratorios Farmacol | 04-Feb-2011 | Buyout/LBO | Pharmaceuticals | ||
| Guangdong Techpool Biochem Pharma | 01-Nov-2010 | Merger/Acquisition | Pharmaceuticals | ||
| GE Healthcare Nycomed Distribution | 27-Apr-2010 | Joint Venture | Distributors (Healthcare) | ||
| Bradley Pharmaceuticals | 21-Feb-2008 | Buyout/LBO | Pharmaceuticals | ||
| ALTANA Pharma | 29-Dec-2006 | Buyout/LBO | Pharmaceuticals |
Nycomed Exits (2)
Nycomed’s most recent exit was on 01-Nov-2010 from Guangdong Techpool Biochem Pharma. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Guangdong Techpool Biochem Pharma | 01-Nov-2010 | Completed |
|
||
| Centrafarm | Merger/Acquisition | Completed |
Nycomed Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ALTANA Pharma | Konstanz, Germany | 2002 | |
| Nycomed Amersham Master Trust | Marlborough, MA |
Nycomed FAQs
-
When was Nycomed founded?
Nycomed was founded in 1873.
-
Where is Nycomed headquartered?
Nycomed is headquartered in Zurich, Switzerland.
-
What is the size of Nycomed?
Nycomed has 12,000 total employees.
-
What industry is Nycomed in?
Nycomed’s primary industry is Pharmaceuticals.
-
Is Nycomed a private or public company?
Nycomed is a Private company.
-
What is the current valuation of Nycomed?
The current valuation of Nycomed is .
-
What is Nycomed’s current revenue?
The current revenue for Nycomed is .
-
How much funding has Nycomed raised over time?
Nycomed has raised $7.92B.
-
Who are Nycomed’s investors?
AlpInvest Partners, Avista Healthcare Partners, Blackstone, Crescent Capital Group, and HarbourVest Partners are 5 of 14 investors who have invested in Nycomed.
-
When was Nycomed acquired?
Nycomed was acquired on 30-Sep-2011.
-
Who acquired Nycomed?
Nycomed was acquired by Takeda Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
